Biotech Growth Trust (the) Plc

Biotech Growth (BIOG)

Buy
Sell
Company name:Biotech Growth Trust (the) Plc
EPIC:BIOGTrading Currency:GBX
Market Sector:SSC5ISIN:GB0000385517
Market Segment:SSMMShare Type:DE
WWW Address:https://www.biotechgt.com/Description:ORD 25P
Industry Sector:EQUITY INVESTMENT INSTRUMENTS
 Price Price Change [%] Bid Offer Open High Low Volume
 1,226.00 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 1,220.00 1,234.00 - - - 7,514
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 511.67 41.73 -0.39 -0.20 - - - 1,750.00 - 1,160.00

Biotech Growth Key Figures

(at previous day's close)
Market Cap.511.67m
Shares In Issue41.73m
Prev. Close1,226.00
PE Ratio- 
Dividend Yield-%
EPS - basic-0.20p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-13.60p
Return On Equity (ROE)-0.01%
Operating Margin6.29%
PEG Factor- 
EPS Growth Rate-120.00%
Dividends PS Growth Rate-%
Net Debt46.56m
Gross Gearing7.40%
Quick Assets6.26m
Net Working Capital-41.80m
Intangibles / Fixed Assets-%
Turnover PS2.36p
Pre-Tax Profit PS0.15p
Retained Profit PS-0.17p
Cash PS3.60p
Net Cash PS-111.57p
Net Tangible Asset Value PS *1,441.17p
Net Asset Value PS1,441.17p
Spread14.00 (1.13%) 

Biotech Growth Balance Sheet

L^BIOG:Liabilities+EQL^BIOG:Assets

Share Price Performance

Sample Period HighLow
1 week1,288.001,190.00
4 weeks1,444.001,190.00
12 weeks1,444.001,190.00
1 year1,750.001,160.00

Share Price Chart (5 years)

Biotech Growth Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1,288.00-62.00-4.811,190.000.101,228.29
4 weeks1,444.00-218.00-15.101,190.000.071,297.68
12 weeks1,332.00-106.00-7.961,190.000.081,326.95
26 weeks1,630.00-404.00-24.791,190.000.101,437.90
1 year1,244.00-18.00-1.451,160.000.101,452.05
3 years810.00416.0051.36596.000.101,034.69
5 years720.00506.0070.28596.000.09936.41

Biotech Growth Key Management Ratios

Biotech Growth Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.97 
Tobin's Q Ratio (excl. intangibles)0.97 
Dividend Yield-%
Market-to-Book Ratio0.85 
Price-to-Pre-Tax Profit PS8,252.71 
Price-to-Retained Profit PS-7,415.48 
Price-to-Cash Flow PS-90.18 
Price-to-Sales PS518.93 
Price-to-Net Tangible Asset Value PS0.85 
Price-to-Cash PS340.66 
Net Working Capital PS-100.16 
Price Pct to Working Capital PS-12.24%
Earnings Yield-%
Average PE658.95 
Years in average4 
PE to PE average-%

Biotech Growth Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing7.17%
Net Gearing (excl. Intangibles)7.17%
Gross Gearing7.40%
Gross Gearing (excl. Intangibles)7.40%
Gearing Under 1 Year7.40%
Gearing Under 1 Year (excl. Intgbl)7.40%
Assets/Equity1.08 
Cash/Equity0.25 
(Liquidity Ratios)
Net Working Capital to Total Assets-6.44%
Current Ratio0.13 
Quick Ratio (Acid Test)0.13 
Liquidity Ratio0.03 
Cash & Equiv/Current Assets23.99%
(Solvency Ratios)
Enterprise Value510.17m
CFO/Sales-5.75 
CFO/Attributable Profit- 
CFO/Assets-0.01 
CFO/Debt-0.12 
Total Debt/Equity Market Value0.09 
Total Debt/Sales48.75 
Total Debt/Pre-Tax Profit775.24 
Total Debt48.07m
Total Debt/Net Current Assets-1.15%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-8.76%
Earn drops > 5% in 10yrs8 
Beta (60-Mnth)Beta (36-Mnth)
-0.3888-0.3307

Biotech Growth Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)0.01%
Return On Assets (ROA)-0.01%
Net Profit Margin-7.00%
Assets Turnover0.00 
Return On Equity (ROE)-0.01%
Return On Investment (ROI)-0.01%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-7.00%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.00 
Fixed Assets Turnover0.00 
Current Assets Turnover0.22 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales532.82 
Debtors-to-Sales369.78%
Debt Collection Period1,349.69Days

Biotech Growth Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
20 Jun 2001FinalGBP0.2031/03/200031/03/200104/07/200106/07/200130/07/20010.20

Biotech Growth Fundamentals

 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
turnover1.58100.00%1.25100.00%1.31100.00%0.99-m
pre tax profit0.8453.11%0.7056.26%0.6650.42%0.06-m
attributable profit0.6038.01%0.5241.33%0.4735.49%-0.07-m
retained profit0.6038.01%0.5241.33%0.4735.49%-0.07-m
eps - basic (p)1.10 1.00 1.00 -0.20 
eps - diluted (p)1.10 1.00 1.00 -0.20 
dividends per share- - - - 

Biotech Growth Balance Sheet

 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
L^BIOG:Liabilities+EQL^BIOG:AssetsL^BIOG:Liabilities+EQL^BIOG:AssetsL^BIOG:Liabilities+EQL^BIOG:AssetsL^BIOG:Liabilities+EQL^BIOG:Assets
 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
ASSETS
fixed assets fixed assets--%--%--%--%m
intangibles intangibles--%--%--%--%m
fixed investments fixed investments445.6799.91%431.1799.99%398.6699.37%643.2799.04%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors0.410.09%0.060.01%2.530.63%4.760.73%m
cash & securities cash & securities--%--%--%1.500.23%m
TOTAL446.07100%431.23100%401.19100%649.53100%m
LIABILITIES
creditors - short creditors - short28.686.43%22.365.18%35.628.88%48.077.40%m
creditors - long creditors - long--%--%--%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL28.686.43%22.365.18%35.628.88%48.077.40%m
EQUITY
ord cap, reserves ord cap, reserves417.4093.57%408.8894.82%365.5791.12%601.4792.60%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL417.4093.57%408.8894.82%365.5791.12%601.4792.60%m
OTHER
NAV Basic747.50 786.80 932.40 - 
NAV Diluted747.50 786.80 932.40 - 

Biotech Growth Cash Flow Statement

31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
Operating CF-4.11-4.40-3.77-5.67m
Pre-Financing CF-11.91-41.4087.17-31.22m
Retained CF13.08--1.50m

Biotech Growth Brokers

NameActivityTypeMnemonicCode
Arbuthnot Securities LimitedMarket Maker(MMF)Broker/DealerARBTALESGB31MKT
J.P. Morgan Cazenove LimitedMarket Maker(MMF)Broker/DealerCAZRCAZEGB2L
Cenkos Securities PlcMarket Maker(MMF)Broker/DealerCNKSCNKOGB21
Collins Stewart Europe LimitedMarket Maker(MMF)Broker/DealerCSCSCSTEGB21
J.P. Morgan Securities LtdMarket Maker(MMF)Broker/DealerJPMSJPMSGB2L
UBS AGMarket Maker(MMF)Broker/DealerUBS.UBSWGB2LEQU
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
LSE
BIOG
Biotech Gr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210802 07:23:19